When man turns to stone: Extraosseous calcification in uremic patients

Kidney International

Volumn 65, Issue 6, 2004, Pages 2447-2462

  Floege, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

End stage renal disease; Fetuin A; Hemodialysis; Mediasclerosis

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY CALCIFICATION; KIDNEY FAILURE; LABORATORY TEST; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; UREMIA;

EID: 2442638775     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00664.x     Document Type: Review

References (99)

1. KALANTAR-ZADEH K, BLOCK G, HUMPHREYS MH, KOPPLE JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63:793-808, 2003
2. WILMER WA, MAGRO CM: Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15:172-186, 2002
3. MILLINER DS, ZINSMEISTER AR, LIEBERMAN E, LANDING B: Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936, 1990
4. LONDON GM, PANNIER B, MARCHAIS SJ, GUERIN AP: Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 11:778-783, 2000
5. KUZELA DC, HUFFER WE, CONGER JD, WINTER SD, HAMMOND WS: Soft tissue calcification in chronic dialysis patients. Am J Pathol 86:403-424, 1977
6. IBELS LS, ALFREY AC, HUFFER WE, et al: Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66:790-796, 1979
7. MAHER ER, YOUNG G, SMYTH-WALSH B, et al: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2:875-877, 1987
8. CONTIGUGLIA SR, ALFREY AC, MILLER NL, et al: Nature of soft tissue calcification in uremia. Kidney Int 4:229-235, 1973
9. REID JD, ANDERSEN ME: Medial calcification (whitlockite) in the aorta. Atherosclerosis 101:213-224, 1993
10. PROUDFOOT D, SHANAHAN CM: Biology of calcification in vascular cells: Intima versus media. Herz 26:245-251, 2001
11. SAKATA N, NOMA A, YAMAMOTO Y, et al: Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 18:1601-1609, 2003
12. MERJANIAN R, BUDOFF M, ADLER S, et al: Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int 64:263-271, 2003
13. MOE SM, O'NEILL KD, DUAN D, et al: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647, 2002
14. NAYIR A, BILGE I, KILICASLAN I, et al: Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041-2047, 2001
15. URA M, SAKATA R, NAKAYAMA Y, et al: The impact of chronic renal failure on atherosclerosis of the internal thoracic arteries. Ann Thorac Surg 71:148-151, 2001
16. OKUDA K, KOBAYASHI S, HAYASHI H, et al: Case-control study of calcification of the hepatic artery in chronic hemodialysis patients: Comparison with the abdominal aorta and splenic artery. J Gastroenterol Hepatol 17:91-95, 2002
17. BITTRICK J, D'CRUZ IA, WALL BM, et al: Differences and similarities between patients with and without end-stage renal disease, with regard to location of intracardiac calcification. Echocardiography 19:1-6, 2002
18. COFAN F, GARCIA S, COMBALIA A, et al: Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy. J Rheumatol 26:379-385, 1999
19. STEINBACH LS, JOHNSTON JO, TAPPER EF, et al: Tumoral calcinosis: Radiologic-pathologic correlation. Skeletal Radiol 24:573-578, 1995
20. SCHWARZ U, BUZELLO M, RITZ E, et al: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 15:218-223, 2000
21. LEGEROS RZ: Formation and transformation of calcium phosphates: Relevance to vascular calcification. Z Kardiol 90(Suppl 3):116-124, 2001
22. OLSSON LF, ODSELIUS R, RIBBE E, HEGBRANT J: Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas. Am J Kidney Dis 38:377-383, 2001
23. LONDON GM, GUERIN AP, MARCHAIS SJ, et al: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
24. GRUPPEN MP, GROOTHOFF JW, PRINS M, et al: Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int 63:1058-1065, 2003
25. BRAUN J, OLDENDORF M, MOSHAGE W, et al: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1996
26. KETTELER M, BONGARTZ P, WESTENFELD R, et al: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361:827-833, 2003
27. GOODMAN WG, GOLDIN J, KUIZON BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
28. HALLIBURTON SS, STILLMAN AE, WHITE RD: Noninvasive quantification of coronary artery calcification: methods and prognostic value. Cleve Clin J Med 69(Suppl 3):S6-11, 2002
29. LONDON GM: Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Semin Dial 16:85-94, 2003
30. SAFAR ME, BLACHER J, PANNIER B, et al: Central pulse pressure and mortality in end-stage renal disease. Hypertension 39:735-738, 2002
31. GUERIN AP, BLACHER J, PANNIER B, et al: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987-992, 2001
32. DOULTON T, SABHARWAL N, CAIRNS HS, et al: Infective endocarditis in dialysis patients: New challenges and old. Kidney Int 64:720-727, 2003
33. RAGGI P, BOULAY A, CHASAN-TABER S, et al: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701, 2002
34. WANG AY, WANG M, Woo J, et al: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 14:159-168, 2003
35. TAYLOR AJ, FEUERSTEIN I, WONG H, et al: Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J 141:463-468, 2001
36. OH J, WUNSCH R, TURZER M, et al: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105, 2002
37. GOLDSMITH DJ, COVIC A, SAMBROOK PA, ACKRILL P: Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron 77:37-43, 1997
38. CHERTOW GM, BURKE SK, RAGGI P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
39. NITTA K, AKIBA T, UCHIDA K, et al: The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42:303-309, 2003
40. AHMED S, O'NEILL KD, HOOD AF, et al: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37:1267-1276, 2001
41. CANAVESE C, CESARANI F, STRATTA C, et al: Dramatic worsening of vascular calcifications after kidney transplantation in spite of early parathyroidectomy. Clin Nephrol 54:487-491, 2000
42. GEFFRIAUD C, ALLINNE E, PAGE B, et al: Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: A case report. Clin Nephrol 38:158-161, 1992
43. STOMPOR T, PASOWICZ M, SULLOWICZ W, et al: An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203-211, 2003
44. TAMASHIRO M, ISEKI K, SUNAGAWA O, et al: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64-69, 2001
45. BONIFACIO DL, MALINENI K, KADAKIA RA, et al: Coronary calcification and cardiac events after percutaneous intervention in dialysis patients. J Cardiovasc Risk 8:133-137, 2001
46. BLOCK GA, PORT FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35:1226-1237, 2000
47. KURO-O M, MATSUMURA Y, AIZAWA H, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51, 1997
48. JONO S, MCKEE MD, MURRY CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-17, 2000
49. GIACHELLI CM, JONO S, SHIOI A, et al: Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:834-37, 2001
50. CHEN NX, O'NEILL KD, DUAN D, MOE SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62:1724-1731, 2002
51. DEMER LL, TINTUT Y, PARHAMI F: Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens 11:437-443, 2002
52. MOE SM, DUAN D, DOEHLE BP, et al: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003-1011, 2003
53. NITTA K, ISHIZUKA T, HORITA S, et al: Soluble osteopontin and vascular calcification in hemodialysis patients. Nephron 89:455-458, 2001
54. MEEMA HE, OREOPOULOS DG, RAPOPORT A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388-394, 1987
55. PROUDFOOT D, DAVIES JD, SKEPPER JN, et al: Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 106:3044-3050, 2002
56. PARHAMI F, BASSERI B, HWANG J, et al: High-density lipoprotein regulates calcification of vascular cells. Circ Res 91:570-576, 2002
57. CALLISTER TQ, RAGGI P, COOIL B, et al: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972-1978, 1998
58. SHIOI A, KATAGI M, OKUNO Y, et al: Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9-16, 2002
59. 3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid horomone-related peptide. Circulation 98:1302-1306, 1998
60. ISHIMURA E, OKUNO S, KITATANI K, et al: Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients - Importance of glycaemic control. Diabetologia 45:1446-1448, 2002
61. YAMAGISHI S, FUJIMORI H, YONEKURA H, et al: Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 258:353-357, 1999
62. PARHAMI F, TINTUT Y, BALLARD A, et al: Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88:954-960, 2001
63. LANGE LA, LANGE EM, BIELAK LF, et al: Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 22:418-423, 2002
64. PEYSER PA, BIELAK LF, CHU JS, et al: Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 106:304-308, 2002
65. JONO S, NISHIZAWA Y, SHIOI A, MORII H: Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:1135-1142, 1997
66. PRICE PA, JUNE HH, BUCKLEY JR, WILLIAMSON MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610-1616, 2001
67. DAVIES MR, LUND RJ, HRUSKA KA: BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14:1559-1567, 2003
68. STEITZ SA, SPEER MY, MCKEE MD, et al: Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035-2046, 2002
69. SPEER MY, MCKEE MD, GULDBERG RE, et al: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196:1047-1055, 2002
70. LUO G, DUCY P, MCKEE MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81, 1997
71. DHORE CR, CLEUTJENS JP, LUTGENS E, et al: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Blol 21:1998-2003, 2001
72. SHANAHAN CM, CARY NR, METCALFE JC, WEISSBERG PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402, 1994
73. MUNROE PB, OLGUNTURK RO, FRYNS JP, et al: Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142-144, 1999
74. RUTSCH F, RUF N, VAINGANKAR S, et al: Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification. Nat Genet 34:379-381, 2003
75. ALFREY AC, SOLOMONS CC: Bone pyrophosphate in uremia and its association with extraosseous calcification. J Clin Invest 57:700-705, 1976
76. OMBRELLINO M, WANG H, YANG H, et al: Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15:181-185, 2001
77. JERSMANN HP, DRANSFIELD I, HART SP: Fetuin-alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond) 105:273-278, 2003
78. PROUDFOOT D, SKEPPER JN, HEGYI L, et al: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87:1055-1062, 2000
79. HEISS A, DUCHESNE A, DENECKE B, et al: Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333-13341, 2003
80. JAHNEN-DECHENT W, SCHINKE T, TRINDL A, et al: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496-31503, 1997
81. PRICE PA, NGUYEN TM, WILLIAMSON MK: Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 278:22153-22160, 2003
82. SCHÄFER C, HEISS A, SCHWARZ A, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366, 2003
83. KITOH C, MIYAGI K, ONOE T, et al: Reversible peritoneal calcification in a patient treated by CAPD. Clin Nephrol 52:329-332, 1999
84. CHAN CT, MARDIROSSIAN S, FARATRO R, RICHARDSON RM: Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 41:225-229, 2003
85. DI LEO C, GALLIENI M, BESTETTI A, et al: Cardiac and pulmonary calcification in a hemodialysis patient: Partial regression 4 years after parathyroidectomy. Clin Nephrol 59:59-63, 2003
86. KURIYAMA S, TOMONARI H, NAKAYAMA M, et al: Successful treatment of tumoral calcinosis using CAPD combined with hemodialysis with low-calcium dialysate. Blood Purif 16:43-48, 1998
87. Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15(Suppl 5):39-57, 2000
88. KATSUMATA K, KUSANO K, HIRATA M, et al: Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64:441-450, 2003
89. DRUEKE TB, MCCARRON DA: Paricalcitol as compared with calcitriol in patients undergoing hemodialysis. N Engl J Med 349:496-499, 2003
90. GOODMAN WG, HLADIK GA, TURNER SA, et al: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13:1017-1024, 2002
91. PRICE PA, FAUS SA, WILLIAMSON MK: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817-824, 2001
92. MOTRO M, SHEMESH J: Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 37:1410-1413, 2001
93. BUSHINSKY DA, SMITH SB, GAVRILOV KL, et al: Chronic acidosis-induced alteration in bone bicarbonate and phosphate. Am J Physiol (Renal Physiol) 285:F532-539, 2003
94. KRONENBERG F, MUNDLE M, LANGLE M, NEYER U: Prevalence and progression of peripheral arterial calcifications in patients with ESRD. Am J Kidney Dis 41:140-148, 2003
95. WATSON KE, BOSTROM K, RAVINDRANATH R, et al: TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93:2106-2113, 1994
96. TOWLER DA, BIDDER M, LATIFI T, et al: Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273:30427-30434, 1998
97. BALICA M, BOSTROM K, SHIN V, et al: Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 95:1954-1960, 1997
98. MORI K, SHIOI A, JONO S, et al: Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:2112-2118, 1999
99. MASUDA I, HIROSE J: Animal models of pathologic calcification. Curr Opin Rheumatol 14:287-291, 2002